Covid-19 drug

Update news Covid-19 drug

Only firm licensed to manufacture Molnupiravir in Vietnam

The Medicine Patent Pool (MPP) on January 20 announced it has granted licenses to manufacture the COVID-19 treatment drug Molnupiravir to 27 pharmaceutical firms worldwide, including Stella Vietnam (Stellapharm).

HCMC proposes to receive 100,000 more Molnupiravir doses

Ho Chi Minh City has asked for 100,000 more Molnupiravir doses.

Is Vietnam’s Covid-19 treatment Favipiravir drug effective?

Vietnam has never included any antiviral drugs in its Covid-19 treatment regimen because of unclear and unproved effectiveness of the drugs in clinical trial results.